About: Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
Creator	Kalimuddin, Shirin Leo, Yee-Sin Chen, Mark I-Cheng Lee, Bernett Pada, Surinder Carissimo, Guillaume Chan, Yi-Hao Tambyah, Paul Lye, David Ng, Lisa Tay, Matthew Young, Barnaby Guek, Jenny Lee, Yi-Pin Low, Hong Naqiah Amrun, Siti Poh, Chek Renia, Laurent Tan, Seow-Yen Chang, Wei Chee, Ling Fong, Siew-Wai Sin, Rhonda Sun, Louisa Torres-Ruesta, Anthony Yeo, Kim-Wah
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: Given the unceasing worldwide surge in COVID-19 cases, there is an imperative need to develop highly specific and sensitive serology assays to define exposure to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). METHODS: Pooled plasma samples from PCR positive COVID-19 patients were used to identify linear B-cell epitopes from a SARS-CoV-2 peptide library of spike (S), envelope (E), membrane (M), and nucleocapsid (N) structural proteins by peptide-based ELISA. Hit epitopes were further validated with 79 COVID-19 patients with different disease severity status, 13 seasonal human CoV, 20 recovered SARS patients and 22 healthy donors. FINDINGS: Four immunodominant epitopes, S14P5, S20P2, S21P2 and N4P5, were identified on the S and N viral proteins. IgG responses to all identified epitopes displayed a strong detection profile, with N4P5 achieving the highest level of specificity (100%) and sensitivity (>96%) against SARS-CoV-2. Furthermore, the magnitude of IgG responses to S14P5, S21P2 and N4P5 were strongly associated with disease severity. INTERPRETATION: IgG responses to the peptide epitopes can serve as useful indicators for the degree of immunopathology in COVID-19 patients, and function as higly specific and sensitive sero-immunosurveillance tools for recent or past SARS-CoV-2 infections. The flexibility of these epitopes to be used alone or in combination will allow for the development of improved point-of-care-tests (POCTs). FUNDING: Biomedical Research Council (BMRC), the Accelerate GAP-funded project (ACCL/19-GAP064-R20H-H) from Agency of Science, Technology and Research (ASTAR), and National Medical Research Council (NMRC) COVID-19 Research fund (COVID19RF-001) and CCGSFPOR20002. ATR is supported by the Singapore International Graduate Award (SINGA), A*STAR.
has issue date	2020-07-22(xsd:dateTime)
bibo:doi	10.1016/j.ebiom.2020.102911
bibo:pmid	32711254
has license	no-cc
sha1sum (hex)	806750509f3de3786cbd3d991acdfcebe34e6571
schema:url	https://doi.org/10.1016/j.ebiom.2020.102911
resource representing a document's title	Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
has PubMed Central identifier	PMC7375792
has PubMed identifier	32711254
schema:publication	EBioMedicine
resource representing a document's body	covid:806750509f3de3786cbd3d991acdfcebe34e6571#body_text
is schema:about of	named entity 'specific' named entity 'infections' named entity 'Given' named entity 'patients' named entity 'SARS-CoV-2' named entity 'specificity' named entity 'Methods' named entity 'HEALTHY' named entity 'BACKGROUND' named entity 'The' named entity 'linear' named entity 'highly' named entity 'library' named entity 'responses' named entity 'SARS-CoV-2' named entity 'peptide' named entity 'viral' named entity 'PCR' named entity 'SARS' named entity 'epitopes' named entity 'IgG' named entity 'immunosurveillance' named entity 'serology' named entity 'SARS-CoV-2' named entity 'nucleocapsid' named entity 'COVID-19' named entity 'COVID' named entity 'nucleocapsid' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'peptide' named entity 'plasma' named entity 'nucleocapsid proteins' named entity 'SARS-CoV-2' named entity 'IgG' named entity 'immunopathology' named entity 'nucleocapsid' named entity 'COVID-19' named entity 'CXR' named entity 'viral protein' named entity 'antibodies' named entity 'coronaviruses' named entity 'ICU' named entity 'NHG' named entity 'epitopes' named entity 'CRP' named entity 'severe pneumonia' named entity 'hypoxia' named entity 'virus transmission' named entity 'sensitivity and specificity' named entity 'epitopes' named entity 'logistic regression' named entity 'COVID' named entity 'IgG' named entity 'immunoassays' named entity 'coronavirus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software